risk sharing

News
Genetic Testing Underutilized in Women With History of Ovarian Cancer
08/22/2017
JCP Editors
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less...
08/22/2017
Journal of Clinical Pathways
Research in Review
Comparative Effectiveness Study Examines Treatment Options for DLBCL
08/18/2017
JCP Editors
A recent study compared the treatment effects and adverse events of first-line chemotherapy regimens in patients with treatment-naïve diffuse large B-cell lymphoma (DLBCL). Rituximab plus cyclophosphamide,...
A recent study compared the treatment effects and adverse events of first-line chemotherapy regimens in patients with treatment-naïve diffuse large B-cell lymphoma (DLBCL). Rituximab plus cyclophosphamide,...
A...
08/18/2017
Journal of Clinical Pathways
Research in Review
Patient Values, Concerns Influence Breast Cancer Treatment Decisions
08/17/2017
JCP Editors
Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...
Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...
...
08/17/2017
Journal of Clinical Pathways
Research in Review
Resistance Mutations Predict Metastatic Patterns in NSCLC
08/17/2017
JCP Editors
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...
...
08/17/2017
Journal of Clinical Pathways
Research in Review
Monotherapy Improves Outcomes in Metastatic Breast Cancer With BRCA Mutation
08/14/2017
JCP Editors
An immuno-agent improves progression-free survival (PFS) and lowers the risk of death for patients with human epidermal growth factor 2 (HER2)-negative metastatic breast cancer and a germline BRCA mutation, according...
An immuno-agent improves progression-free survival (PFS) and lowers the risk of death for patients with human epidermal growth factor 2 (HER2)-negative metastatic breast cancer and a germline BRCA mutation, according...
An...
08/14/2017
Journal of Clinical Pathways
Research in Review
Pancreatic Cancer Guidelines Do Not Cover Some Targetable Mutations
08/11/2017
JCP Editors
Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...
Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...
...
08/11/2017
Journal of Clinical Pathways
Research in Review
Double Dosage of ALK Inhibitor Improves Outcomes in NSCLC
08/09/2017
JCP Editors
Increasing the standard dose of an anaplastic lymphoma kinase (ALK) inhibitor for the treatment of non-small cell lung cancer (NSCLC) improves objective response rates (ORR) by 9% with limited additional toxicity,...
Increasing the standard dose of an anaplastic lymphoma kinase (ALK) inhibitor for the treatment of non-small cell lung cancer (NSCLC) improves objective response rates (ORR) by 9% with limited additional toxicity,...
...
08/09/2017
Journal of Clinical Pathways
Research in Review
Pediatric APL Outcomes Improved By Arsenic Trioxide Consolidation
08/03/2017
JCP Editors
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
Advance Directives, QoL-Focused Care Needed for Cancer Patients With Delirium in the ED
08/03/2017
JCP Editors
Patients with advanced cancer who visit the emergency department (ED) with delirium have increased rates of hospitalizations and ICU admissions, along with decreased survival rates, according to a recent study...
Patients with advanced cancer who visit the emergency department (ED) with delirium have increased rates of hospitalizations and ICU admissions, along with decreased survival rates, according to a recent study...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
Dose Escalation of CML Treatment Improves Molecular Response Rates
08/02/2017
JCP Editors
Patients with chronic myeloid leukemia (CML) in the chronic phase may achieve molecular response with safe and effective treatment dose escalation, according to a recent study. ----- Related Content CML Mutations...
Patients with chronic myeloid leukemia (CML) in the chronic phase may achieve molecular response with safe and effective treatment dose escalation, according to a recent study. ----- Related Content CML Mutations...
...
08/02/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use